<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ESALY</title>
    <link />
    <description>Headlines for Eisai Co., Ltd (ADR)</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Why Arena Pharmaceuticals Shares Slimmed Down</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/03/why-arena-pharmaceuticals-slimmed-down/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 03 May 2013 13:43:00 GMT</pubDate>
    </item>
    <item>
      <title>Will This Obesity Biotech's Latest Scheme Boost Sales?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/06/will-this-obesity-biotechs-latest-scheme-boost-sal/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 06 Mar 2013 10:25:00 GMT</pubDate>
    </item>
    <item>
      <title>When Will This Obesity Drug Launch?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/04/when-will-this-obesity-drug-launch/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 04 Mar 2013 15:14:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Reasons Why Eisai Should Purchase Arena Pharmaceuticals</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/10/15/3-reasons-why-eisai-should-purchase-arena-pharmace/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 15 Oct 2012 11:17:00 GMT</pubDate>
    </item>
  </channel>
</rss>
